In the Press
May 20, 2020

What Next For Medtech And Investors Post-Coronavirus? (In Vivo)

If a post-COVID-19 economic recovery starts properly in September, as some have suggested, how swift would a return to normal be for medtech and life sciences businesses? It depends on what the new normal looks like, suggest Goodwin Technology and Life Sciences partners Sophie McGrath and Tim Worden. Read the article in In Vivo here